6 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Erenumab for Episodic Migraine ... #EBM #Neuro #Erenumab ... #Migraine #CGRP ... VisualAbstract #NEJM
Assessment and Management of seizures #Management #EM #Neuro #Seizure #Assessment #Algorithm #Ddxof
Assessment and Management ... seizures #Management #EM ... #Neuro #Seizure ... #Assessment #Algorithm ... #Ddxof
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Differential Diagnosis and Evaluation of Hyponatremia:
1) Identification of onset (acute vs. chronic)
2) Presence of symptoms (HA,
, seizures) 3) Assessment ... history #Diagnosis #EM ... #IM #Nephro #Hyponatremia ... #Differential #Algorithm ... #Ddxof